CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: hexoside
Accession: CHEBI:35313
browse the term
Synonyms: related_synonym: hexosides
G
IL18
interleukin 18
multiple interactions
EXP
mogroside V inhibits the reaction [Particulate Matter results in increased expression of IL18 mRNA]
CTD
PMID:35134483
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
G
LOC110258578
interleukin-1 beta-like
increases expression
EXP
mogroside V results in increased expression of IL1B mRNA
CTD
PMID:35134483
G
NLRP3
NLR family pyrin domain containing 3
multiple interactions
EXP
mogroside V inhibits the reaction [Particulate Matter results in increased expression of NLRP3 protein]
CTD
PMID:35134483
NCBI chr 2:56,892,241...56,977,412
Ensembl chr 2:56,892,243...56,977,228
G
NOS2
nitric oxide synthase 2
multiple interactions
EXP
mogroside V inhibits the reaction [Particulate Matter results in increased expression of NOS2 mRNA]
CTD
PMID:35134483
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
G
PTGS2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
mogroside V inhibits the reaction [Particulate Matter results in increased expression of PTGS2 mRNA]
CTD
PMID:35134483
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
mogroside V inhibits the reaction [Particulate Matter results in increased phosphorylation of RELA protein]
CTD
PMID:35134483
NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469
G
TNF
tumor necrosis factor
multiple interactions
EXP
mogroside V inhibits the reaction [Particulate Matter results in increased expression of TNF mRNA]
CTD
PMID:35134483
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
G
SLC5A1
solute carrier family 5 member 1
decreases expression
EXP
Neomycin results in decreased expression of SLC5A1 mRNA; Neomycin results in decreased expression of SLC5A1 protein
CTD
PMID:12927799
NCBI chr14:48,566,400...48,704,145
Ensembl chr14:48,628,224...48,705,841
G
IL10
interleukin 10
decreases expression
EXP
notoginsenoside R1 results in decreased expression of IL10 protein
CTD
PMID:25721049
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL4
interleukin 4
decreases expression
EXP
notoginsenoside R1 results in decreased expression of IL4 protein
CTD
PMID:25721049
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
5066
chemical entity
5066
atom
5057
nonmetal atom
5019
oxygen atom
4896
oxygen molecular entity
4896
organooxygen compound
4703
carbohydrates and carbohydrate derivatives
123
carbohydrate derivative
112
glycosyl compound
50
glycoside
25
hexoside
10
(2R,3R,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)piperidin-3-yl hexopyranoside
0
N-benzyloxycarbonylaminoethyl-4-azido-3-O-benzoyl-2-O-methyl-4,6-dideoxy-alpha-D-glucopyranoside
0
descarbamoylnovobiocin
0
desmethyldescarbamoylnovobiocin
0
fructoside +
0
galactoside +
0
glucoside +
10
guloside +
0
mannoside +
0
novclobiocin 109
0
novobiocin
0
Path 2
CHEBI ontology
5066
subatomic particle
5057
composite particle
5057
hadron
5057
baryon
5057
nucleon
5057
atomic nucleus
5057
atom
5057
main group element atom
5026
p-block element atom
5023
carbon group element atom
4940
carbon atom
4939
organic molecular entity
4939
heteroorganic entity
4779
organochalcogen compound
4741
organooxygen compound
4703
carbohydrates and carbohydrate derivatives
123
carbohydrate
123
carbohydrate derivative
112
glycosyl compound
50
glycoside
25
hexoside
10
(2R,3R,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)piperidin-3-yl hexopyranoside
0
N-benzyloxycarbonylaminoethyl-4-azido-3-O-benzoyl-2-O-methyl-4,6-dideoxy-alpha-D-glucopyranoside
0
descarbamoylnovobiocin
0
desmethyldescarbamoylnovobiocin
0
fructoside +
0
galactoside +
0
glucoside +
10
guloside +
0
mannoside +
0
novclobiocin 109
0
novobiocin
0